‘Bharat Biotech submitting data regularly, very quickly': WHO official on Covaxin approval
"Let me say that Bharat has been submitting data regularly and very quickly, but they submitted the last batch of data on the 18th of October," Dr Mariangela Simao, Assistant Director-General said.
Oct 29, 2021, 07:26 AM IST
Bharat Biotech's Covaxin third phase trial proven successful
The third phase trial of India's indigenous vaccine Covaxin has proven successful. Bharat Biotech vaccine was tested in twenty-five cities of the country. Covaxin has shown to be 81% efficacy in trials. ICMR tweeted that it was a big win for self-reliant India.
Mar 04, 2021, 10:50 AM IST
